Therapy-Related Acute Promyelocytic Leukemia Developed During Pembrolizumab Therapy.

Ober, Cecily E; Jacocks, Charles E; Osswald, Michael B

Ober, Cecily E; Jacocks, Charles E; Osswald, Michael B.

Afiliação

Ober CE; Internal Medicine, San Antonio Uniformed Services Health Education Consortium, San Antonio, USA.
Jacocks CE; Hematology and Oncology, San Antonio Uniformed Services Health Education Consortium, San Antonio, USA.
Osswald MB; Hematology and Oncology, San Antonio Uniformed Services Health Education Consortium, San Antonio, USA.

Cureus ; 15(4): e37919, 2023 Apr.

Article em En | MEDLINE | ID: mdl-37220434

Palavras-chave

acute myeloid leukemia; acute promyelocytic leukemia; immune-checkpoint inhibitors; pembrolizumab; therapy-related acute promyelocytic leukemia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cureus Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google